Find Research Outputs

Search concepts
Selected filters

Publication Year

  • 2020
  • 2019
  • 2018
  • 2017
  • 2016

Author

  • Wu-Chou Su
2019
Open Access
2020

Nivolumab safety and efficacy in advanced, platinum-resistant, non-small cell lung cancer, radical radiotherapy-ineligible patients: A phase II study in Taiwan

Chen, Y. M., Chih-Hsin Yang, J., Su, W. C., Chong, I. W., Hsia, T. C., Lin, M. C., Chang, G. C., Chiu, C. H., Ho, C. C., Wu, S. Y., Hung, J. Y., Wang, C. C., Yang, T. Y. & Yu, C. J., 2020 Jan 1, (Accepted/In press) In : Journal of the Formosan Medical Association.

Research output: Contribution to journalArticle

Open Access

Tuberculosis infection and lung adenocarcinoma: Mendelian randomization and pathway analysis of genome-wide association study data from never-smoking Asian women

Wong, J. Y. Y., Zhang, H., Hsiung, C. A., Shiraishi, K., Yu, K., Matsuo, K., Wong, M. P., Hong, Y. C., Wang, J., Seow, W. J., Wang, Z., Song, M., Kim, H. N., Chang, I. S., Chatterjee, N., Hu, W., Wu, C., Mitsudomi, T., Zheng, W., Kim, J. H. & 166 others, Seow, A., Caporaso, N. E., Shin, M. H., Chung, L. P., An, S. J., Wang, P., Yang, Y., Zheng, H., Yatabe, Y., Zhang, X. C., Kim, Y. T., Cai, Q., Yin, Z., Kim, Y. C., Bassig, B. A., Chang, J., Ho, J. C. M., Ji, B. T., Daigo, Y., Ito, H., Momozawa, Y., Ashikawa, K., Kamatani, Y., Honda, T., Hosgood, H. D., Sakamoto, H., Kunitoh, H., Tsuta, K., Watanabe, S. I., Kubo, M., Miyagi, Y., Nakayama, H., Matsumoto, S., Tsuboi, M., Goto, K., Shi, J., Song, L., Hua, X., Takahashi, A., Goto, A., Minamiya, Y., Shimizu, K., Tanaka, K., Wei, F., Matsuda, F., Su, J., Kim, Y. H., Oh, I. J., Song, F., Su, W. C., Chen, Y. M., Chang, G. C., Chen, K. Y., Huang, M. S., Chien, L. H., Xiang, Y. B., Park, J. Y., Kweon, S. S., Chen, C. J., Lee, K. M., Blechter, B., Li, H., Gao, Y. T., Qian, B., Lu, D., Liu, J., Jeon, H. S., Hsiao, C. F., Sung, J. S., Tsai, Y. H., Jung, Y. J., Guo, H., Hu, Z., Wang, W. C., Chung, C. C., Burdett, L., Yeager, M., Hutchinson, A., Berndt, S. I., Wu, W., Pang, H., Li, Y., Choi, J. E., Park, K. H., Sung, S. W., Liu, L., Kang, C. H., Zhu, M., Chen, C. H., Yang, T. Y., Xu, J., Guan, P., Tan, W., Wang, C. L., Hsin, M., Sit, K. Y., Ho, J., Chen, Y., Choi, Y. Y., Hung, J. Y., Kim, J. S., Yoon, H. I., Lin, C. C., Park, I. K., Xu, P., Wang, Y., He, Q., Perng, R. P., Chen, C. Y., Vermeulen, R., Wu, J., Lim, W. Y., Chen, K. C., Li, Y. J., Li, J., Chen, H., Yu, C. J., Jin, L., Chen, T. Y., Jiang, S. S., Liu, J., Yamaji, T., Hicks, B., Wyatt, K., Li, S. A., Dai, J., Ma, H., Jin, G., Song, B., Wang, Z., Cheng, S., Li, X., Ren, Y., Cui, P., Iwasaki, M., Shimazu, T., Tsugane, S., Zhu, J., Yang, K., Jiang, G., Fei, K., Wu, G., Lin, H. C., Chen, H. L., Fang, Y. H., Tsai, F. Y., Hsieh, W. S., Yu, J., Stevens, V. L., Laird-Offringa, I. A., Marconett, C. N., Rieswijk, L., Chao, A., Yang, P. C., Shu, X. O., Wu, T., Wu, Y. L., Lin, D., Chen, K., Zhou, B., Huang, Y. C., Kohno, T., Shen, H., Chanock, S. J., Rothman, N. & Lan, Q., 2020 Mar, In : Genomics. 112, 2, p. 1223-1232 10 p.

Research output: Contribution to journalArticle

Open Access
2019
Open Access

Erratum: A novel derivative of betulinic acid, SYK023, suppresses lung cancer growth and malignancy (Oncotarget (2015) 6 (13671–13687) DOI: 10.18632/oncotarget.3701)

Hsu, T. I., Chen, Y. J., Hung, C. Y., Wang, Y. C., Lin, S. J., Su, W. C., Lai, M. D., Kim, S. Y., Wang, Q., Qian, K., Goto, M., Zhao, Y., Kashiwada, Y., Lee, K. H., Chang, W. C. & Hung, J. J., 2019 Jan 1, In : Oncotarget. 10, 60, p. 6536-6537 2 p.

Research output: Contribution to journalComment/debate

2016

Positive feedback regulation between IL10 and EGFR promotes lung cancer formation

Hsu, T. I., Wang, Y-C., Hung, C. Y., Yu, C. H., Su, W-C., Chang, W. C. & Hung, J-J., 2016 Apr 12, In : Oncotarget. 7, 15, p. 20840-20854 15 p.

Research output: Contribution to journalArticle

10 Citations (Scopus)

Elucidating Quantum Confinement in Graphene Oxide Dots Based on Excitation-Wavelength-Independent Photoluminescence

Yeh, T. F., Huang, W. L., Chung, C. J., Chiang, I. T., Chen, L. C., Chang, H. Y., Su, W. C., Cheng, C., Chen, S. J. & Teng, H., 2016 Jun 2, In : Journal of Physical Chemistry Letters. 7, 11, p. 2087-2092 6 p.

Research output: Contribution to journalArticle

69 Citations (Scopus)
2017
11 Citations (Scopus)

Erratum: Oncoprotein ZNF322A transcriptionally deregulates alpha-adducin, cyclin D1 and p53 to promote tumor growth and metastasis in lung cancer (Oncogene (2016) 35 18 (2357-2369))

Jen, J., Lin, L. L., Lo, F. Y., Chen, H. T., Liao, S. Y., Tang, Y. A., Su, W. C., Salgia, R., Hsu, C. L., Huang, H. C., Juan, H. F. & Wang, Y. C., 2017 Aug 1, In : Oncogene. 36, 31, 1 p.

Research output: Contribution to journalComment/debate

Open Access
7 Citations (Scopus)
2020

Assessment of Serological Early Biomarker Candidates for Lung Adenocarcinoma by using Multiple Reaction Monitoring-Mass Spectrometry

Wu, H. Y., Pan, Y. Y., Kopylov, A. T., Zgoda, V., Ma, M. C., Wang, C. H., Su, W. C., Lai, W. W., Cheng, P. N. & Liao, P. C., 2020 Jan 1, (Accepted/In press) In : Proteomics - Clinical Applications. 1900095.

Research output: Contribution to journalArticle

2017

Liquid biopsy genotyping in lung cancer: Ready for clinical utility?

Huang, W. L., Chen, Y. L., Yang, S. C., Ho, C. L., Wei, F., Wong, D. T., Su, W. C. & Lin, C. C., 2017 Jan 1, In : Oncotarget. 8, 11, p. 18590-18608 19 p.

Research output: Contribution to journalArticle

26 Citations (Scopus)
2018
6 Citations (Scopus)
2017

Activity and safety of AZD3759 in EGFR-mutant non-small-cell lung cancer with CNS metastases (BLOOM): a phase 1, open-label, dose-escalation and dose-expansion study

Ahn, M. J., Kim, D. W., Cho, B. C., Kim, S. W., Lee, J. S., Ahn, J. S., Kim, T. M., Lin, C. C., Kim, H. R., John, T., Kao, S., Goldman, J. W., Su, W. C., Natale, R., Rabbie, S., Harrop, B., Overend, P., Yang, Z. & Yang, J. C. H., 2017 Nov, In : The Lancet Respiratory Medicine. 5, 11, p. 891-902 12 p.

Research output: Contribution to journalArticle

33 Citations (Scopus)
2018

Durvalumab as third-line or later treatment for advanced non-small-cell lung cancer (ATLANTIC): an open-label, single-arm, phase 2 study

ATLANTIC Investigators, 2018 Apr, In : The Lancet Oncology. 19, 4, p. 521-536 16 p.

Research output: Contribution to journalArticle

136 Citations (Scopus)
2019

Real-world outcomes of NSCLC patients receiving tissue or circulating tumor DNA-guided osimertinib treatment

Su, P. L., Yang, S. C., Chen, Y. L., Wu, Y. L., Lin, C. Y., Chang, W. Y., Tseng, Y. L., Lai, W. W., Ho, C. L., Lin, C. C. & Su, W. C., 2019 Oct 1, In : Cancer medicine. 8, 13, p. 5939-5947 9 p.

Research output: Contribution to journalArticle

Open Access
1 Citation (Scopus)
2018

Phase Ib/II Study of Capmatinib (INC280) Plus Gefitinib after Failure of Epidermal Growth Factor Receptor (EGFR) Inhibitor Therapy in Patients with EGFR-Mutated, MET Factor-Dysregulated Non-Small-Cell Lung Cancer

Wu, Y. L., Zhang, L., Kim, D. W., Liu, X., Lee, D. H., Yang, J. C. H., Ahn, M. J., Vansteenkiste, J. F., Su, W. C., Felip, E., Chia, V., Glaser, S., Pultar, P., Zhao, S., Peng, B., Akimov, M. & Tan, D. S. W., 2018 Nov 1, In : Journal of Clinical Oncology. 36, 31, p. 3101-3109 9 p.

Research output: Contribution to journalArticle

43 Citations (Scopus)
2019
Open Access
2 Citations (Scopus)

Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial

Mok, T. S. K., Wu, Y. L., Kudaba, I., Kowalski, D. M., Cho, B. C., Turna, H. Z., Castro, G., Srimuninnimit, V., Laktionov, K. K., Bondarenko, I., Kubota, K., Lubiniecki, G. M., Zhang, J., Kush, D., Lopes, G., Gomez Aubin, G., Fein, L., Kaen, D., Kowalyszyn, R., Lerzo, G. & 236 others, Martinengo, G., Molina, M., Richardet, E., Picon, P., Varela, M., Zarba, J. J., de Azevedo, S. J., Barrios, C. H., Beato, C., Cerny, C. A. S., De Marchi, P. R. M., Fernandes, G., Franke, F. A., Freitas, H., Girotto, G., Lopes, V., Santos, L., Costa, M. A., Shimada, A. K., Smaletz, O., Soares, J. P. H., Victorino, A. P., Ferreira, C., Koleva, M., Koynov, K., Micheva, R., Deliverski, T., Milanova, Z., Doganov, B., Cheng, S., De Angelis, F., Speranza, G., Juergens, R. A., Ksienski, D., Fenton, D., Aren, O., Caglevic, C., Galindo, H., Rey, F., Chang, J., Chen, G., Chen, X., Ouyang, X., Cheng, Y., Ding, Z., Hou, M., Fan, Y., Feng, J., He, J., He, Y., Hu, Y., Li, W., Liu, X., Liu, Z., Lu, S., Qin, S., Tang, Q., Wang, B., Wang, K., Zhang, L., Zhang, X., Zhao, J., Wang, J., Zhou, C., Zhou, J., Zhou, Q., Wu, Y., Cardona, A., Duarte, R., Gomez Wolff, L., Zambrano, A., Vallejo, M., Havel, L., Kolek, V., Kolman, P., Koubkova, L., Petruzelka, L., Popelkova, P., Roubec, J., Vanasek, J., Vlasek, T., Jaal, J., Kuusk, G., Avendano, O., Castro, H., Lopez, K., Sandoval, M., Ho, C. M. J., Lo, S. H., Laczo, I., Piko, B., Ostoros, G., Aoe, K., Fujisaka, Y., Hirashima, T., Horiike, A., Hosomi, Y., Hotta, K., Ichiki, M., Imamura, F., Iwamoto, Y., Kasahara, K., Katakami, N., Kato, T., Murakami, S., Kawaguchi, T., Kishi, K., Kubota, K., Kurata, T., Torii, Y., Nakahara, Y., Nishimura, T., Ohira, T., Saka, H., Sawa, T., Seki, N., Sugawara, S., Takahashi, K., Takigawa, N., Tanaka, H., Yamada, K., Yokoyama, T., Yokoyama, T., Yoshioka, H., Kudaba, I., Purkalne, G., Stara, Z., Cesas, A., Cicenas, S., Zemaitis, M., How, S. H., Liam, C. K., Ong, C. K., Tho, L. M., Arrieta Rodriguez, O., de The Bustamante Valles, F., Hernandez Hernandez, C., Mas, L., Vera, L., Salas, J., Tejada, H., Edusma-Dy, R., Galvez, C., Ladrera, G. E. I., Tan Chun Bing, J., Jassem, J., Kalinka-Warzocha, E., Karaszewska, B., Kazarnowicz, A., Kowalski, D., Lesniewski Kmak, K., Ramlau, R., Araujo, A., Barata, F., Gil, N., Hespanhol, V., Alexandru, A., Dediu, M., Cherciu, N., Ciurescu, D., Ganea, D., Miron, L., Sirbu, D., Turdean, M., Emelyanov, S., Karaseva, N., Kuzina, L., Lazarev, S., Lifirenko, I., Bolotina, L., Lipatov, O., Ovchinnikova, E., Matrosova, M., Alyasova, A., Poltoratsky, A., Taranov, P., Zarubenkov, O., Cohen, G., Dreosti, L., Seolwane, F., Hall, J., Hart, G., Jordaan, C., Buddu, S., Botha, M., Landers, G., Rappaport, B., Ruff, P., Shepherd, L., Szpak, W., Ahn, M. J., Cho, B. C., Kim, J. H., Bergstrom, P., Ohman, R., Griph, H., Betticher, D., Ochsenbein, A., Zippelius, A., Chan, G. C., Chiu, C. H., Hsia, T. C., Su, W. C., Yang, C. H., Ativitavas, T., Danchaivijitr, P., Srimuninnimit, V., Seetalarom, K., Sookprasert, A., Sriuranpong, V., Altundag, O., Cay Senler, F., Erman, M., Goksel, T., Goker, E., Ozyilkan, O., Seker, M., Gumus, M., Turna, H., Yumuk, F., Adamchuk, G., Bondarenko, I., Ivashchuk, O., Ponomarova, O., Rusyn, A., Shevnya, S., Shparyk, Y., Sinielnikov, I., Andrusenko, O., Trukhyn, D., Ursol, G., Vynnychenko, I., Nguyen, T. Q., Pham, X. D., Castro, G. & Kubota, K., 2019 May 4, In : The Lancet. 393, 10183, p. 1819-1830 12 p.

Research output: Contribution to journalArticle

223 Citations (Scopus)

Ramucirumab plus erlotinib in patients with untreated, EGFR-mutated, advanced non-small-cell lung cancer (RELAY): a randomised, double-blind, placebo-controlled, phase 3 trial

Nakagawa, K., Garon, E. B., Seto, T., Nishio, M., Ponce Aix, S., Paz-Ares, L., Chiu, C. H., Park, K., Novello, S., Nadal, E., Imamura, F., Yoh, K., Shih, J. Y., Au, K. H., Moro-Sibilot, D., Enatsu, S., Zimmermann, A., Frimodt-Moller, B., Visseren-Grul, C., Reck, M. & 96 others, Chu, Q., Cortot, A., Pujol, J. L., Fabre, E., Lamour, C., Bischoff, H., Kollmeier, J., Kimmich, M., Engel-Riedel, W., Hammerschmidt, S., Schütte, W., Syrigos, K., Ho, J. C. M., Au, K. H., Ardizzoni, A., Pasello, G., Gregorc, V., Del Conte, A., Galetta, D., Takahashi, T., Kumagai, T., Hotta, K., Goto, Y., Hosomi, Y., Sakai, H., Takiguchi, Y., Kim, Y. H., Kurata, T., Yamaguchi, H., Daga, H., Okamoto, I., Satouchi, M., Ikeda, S., Kasahara, K., Atagi, S., Azuma, K., Aoe, K., Horio, Y., Yamamoto, N., Tanaka, H., Watanabe, S., Nogami, N., Ozaki, T., Koyama, R., Hirashima, T., Kaneda, H., Tomii, K., Fujita, Y., Seike, M., Nishimura, N., Kato, T., Ichiki, M., Saka, H., Hirano, K., Nakahara, Y., Sugawara, S., Kim, S. W., Min, Y. J., Lee, H. W., Kang, J. H., An, H. J., Lee, K. H., Kim, J. S., Lee, G. W., Lee, S. Y., Alexandru, A., Udrea, A. A., Juan-Vidal, Ó., Nadal-Alforja, E., Gil-Bazo, I., Ponce-Aix, S., Rubio-Viqueira, B., Alonso Garcia, M., Felip Font, E., Fuentes Pradera, J., Coves Sarto, J., Lin, M. C., Su, W. C., Hsia, T. C., Chang, G. C., Wei, Y. F., Su, J., Cicin, I., Goksel, T., Harputluoglu, H., Ozyilkan, O., Henning, I., Popat, S., Hatcher, O., Mileham, K., Acoba, J., Garon, E., Jung, G., Raj, M., Martin, W. & Dakhil, S., 2019 Dec, In : The Lancet Oncology. 20, 12, p. 1655-1669 15 p.

Research output: Contribution to journalArticle

15 Citations (Scopus)
2016

Handheld energy-efficient magneto-optical real-time quantitative PCR device for target DNA enrichment and quantification

Li, T. J., Chang, C. M., Chang, P. Y., Chuang, Y. C., Huang, C. C., Su, W. C. & Shieh, D. B., 2016 Jun 3, In : NPG Asia Materials. 8, 6, e277.

Research output: Contribution to journalArticle

11 Citations (Scopus)

Fanconi anemia genes in lung adenocarcinoma - A pathway-wide study on cancer susceptibility

Yang, S. Y., Hsiung, C. N., Li, Y. J., Chang, G. C., Tsai, Y. H., Chen, K. Y., Huang, M. S., Su, W. C., Chen, Y. M., Hsiung, C. A., Yang, P. C., Chen, C. J., Wu, P. E., Yu, J. C., Shen, C. Y. & Hsu, H. M., 2016 Feb 3, In : Journal of biomedical science. 23, 1, 23.

Research output: Contribution to journalArticle

9 Citations (Scopus)
2018

Excellent treatment response with pembrolizumab in a lung cancer patient who developed immune-mediated acute motor/sensory axonal polyneuropathy

Yen, C. C., Su, H. C., Chu, C. Y., Lai, S. J., Yan, J. J., Su, W. P. & Su, W. C., 2018 Jun, In : Lung Cancer. 120, p. 149-151 3 p.

Research output: Contribution to journalLetter

2016

Meta-analysis of genome-wide association studies identifies multiple lung cancer susceptibility loci in never-smoking Asian women

Wang, Z., Seow, W. J., Shiraishi, K., Hsiung, C. A., Matsuo, K., Liu, J., Chen, K., Yamji, T., Yang, Y., Chang, I. S., Wu, C., Hong, Y. C., Burdett, L., Wyatt, K., Chung, C. C., Li, S. A., Yeager, M., Hutchinson, A., Hu, W., Caporaso, N. & 130 others, Landi, M. T., Chatterjee, N., Song, M., Fraumeni, J. F., Kohno, T., Yokota, J., Kunitoh, H., Ashikawa, K., Momozawa, Y., Daigo, Y., Mitsudomi, T., Yatabe, Y., Hida, T., Hu, Z., Dai, J., Ma, H., Jin, G., Song, B., Wang, Z., Cheng, S., Yin, Z., Li, X., Ren, Y., Guan, P., Chang, J., Tan, W., Chen, C. J., Chang, G. C., Tsai, Y. H., Su, W. C., Chen, K. Y., Huang, M. S., Chen, Y. M., Zheng, H., Li, H., Cui, P., Guo, H., Xu, P., Liu, L., Iwasaki, M., Shimazu, T., Tsugane, S., Zhu, J., Jiang, G., Fei, K., Park, J. Y., Kim, Y. H., Sung, J. S., Park, K. H., Kim, Y. T., Jung, Y. J., Kang, C. H., Park, I. K., Kim, H. N., Jeon, H. S., Choi, J. E., Choi, Y. Y., Kim, J. H., Oh, I. J., Kim, Y. C., Sung, S. W., Kim, J. S., Yoon, H. I., Kweon, S. S., Shin, M. H., Seow, A., Chen, Y., Lim, W. Y., Liu, J., Wong, M. P., Lee, V. H. F., Bassig, B. A., Tucker, M., Berndt, S. I., Chow, W. H., Ji, B. T., Wang, J., Xu, J., Sihoe, A. D. L., Ho, J. C. M., Chan, J. K. C., Wang, J. C., Lu, D., Zhao, X., Zhao, Z., Wu, J., Chen, H., Jin, L., Wei, F., Wu, G., An, S. J., Zhang, X. C., Su, J., Wu, Y. L., Gao, Y. T., Xiang, Y. B., He, X., Li, J., Zheng, W., Shu, X. O., Cai, Q., Klein, R., Pao, W., Lawrence, C., Hosgood, H. D., Hsiao, C. F., Chien, L. H., Chen, Y. H., Chen, C. H., Wang, W. C., Chen, C. Y., Wang, C. L., Yu, C. J., Chen, H. L., Su, Y. C., Tsai, F. Y., Chen, Y. S., Li, Y. J., Yang, T. Y., Lin, C. C., Yang, P. C., Wu, T., Lin, D., Zhou, B., Yu, J., Shen, H., Kubo, M., Chanock, S. J., Rothman, N. & Lan, Q., 2016 Feb 1, In : Human Molecular Genetics. 25, 3, p. 620-629 10 p.

Research output: Contribution to journalArticle

22 Citations (Scopus)

Vinflunine-gemcitabine versus vinflunine-carboplatin as first-line chemotherapy in cisplatin-unfit patients with advanced urothelial carcinoma: Results of an international randomized phase II trial (JASINT1)

De Santis, M., Wiechno, P. J., Bellmunt, J., Lucas, C., Su, W. C., Albiges, L., Lin, C. C., Senkus-Konefka, E., Flechon, A., Mourey, L., Necchi, A., Loidl, W. C., Retz, M. M., Vaissière, N. & Culine, S., 2016 Mar 1, In : Annals of Oncology. 27, 3, p. 449-454 6 p., mdv609.

Research output: Contribution to journalArticle

29 Citations (Scopus)
2017

Wheat germ agglutinin-induced paraptosis-like cell death and protective autophagy is mediated by autophagy-linked FYVE inhibition

Tsai, T. L., Wang, H. C., Hung, C. H., Lin, P. C., Lee, Y. S., Chen, H. H. W. & Su, W. C., 2017 Jan 1, In : Oncotarget. 8, 53, p. 91209-91222 14 p.

Research output: Contribution to journalArticle

3 Citations (Scopus)
2016

Variants of ubiquitin-specific peptidase 24 play a crucial role in lung cancer malignancy

Wang, Y-C., Wang, S. A., Chen, P. H., Hsu, T. I., Yang, W. B., Chuang, Y. P., Su, W-C., Liaw, H-J., Chang, W. C. & Hung, J-J., 2016 Jul 14, In : Oncogene. 35, 28, p. 3669-3680 12 p.

Research output: Contribution to journalArticle

5 Citations (Scopus)

Oncoprotein ZNF322A transcriptionally deregulates alpha-adducin, cyclin D1 and p53 to promote tumor growth and metastasis in lung cancer

Jen, J., Lin, L. L., Chen, H. T., Liao, S. Y., Lo, F. Y., Tang, Y. A., Su, W. C., Salgia, R., Hsu, C. L., Huang, H. C., Juan, H. F. & Wang, Y. C., 2016 May 5, In : Oncogene. 35, 18, p. 2357-2369 13 p.

Research output: Contribution to journalArticle

23 Citations (Scopus)
2017

Modulation of Biomarker Expression by Osimertinib: Results of the Paired Tumor Biopsy Cohorts of the AURA Phase I Trial

Thress, K. S., Jacobs, V., Angell, H. K., Yang, J. C. H., Sequist, L. V., Blackhall, F., Su, W. C., Schuler, M., Wolf, J., Gold, K. A., Cantarini, M., Barrett, J. C. & Jänne, P. A., 2017 Oct, In : Journal of Thoracic Oncology. 12, 10, p. 1588-1594 7 p.

Research output: Contribution to journalArticle

7 Citations (Scopus)

Successful AZD9291 Therapy in Advanced Non–Small Cell Lung Cancer after Failure of HM61713

Chen, C. W., Kuo, C. W., Chen, Y. L., Ho, C. L., Su, W. C. & Lin, C. C., 2017 Jun, In : Journal of Thoracic Oncology. 12, 6, p. e72-e74

Research output: Contribution to journalLetter

3 Citations (Scopus)
2018
Open Access
1 Citation (Scopus)
2017

EGF-mediated inhibition of ubiquitin-specific peptidase 24 expression has a crucial role in tumorigenesis

Wang, S. A., Wang, Y. C., Chuang, Y. P., Huang, Y. H., Su, W. C., Chang, W. C. & Hung, J. J., 2017 May 25, In : Oncogene. 36, 21, p. 2930-2945 16 p.

Research output: Contribution to journalArticle

7 Citations (Scopus)
2018

Electric Field–Induced Release and Measurement Liquid Biopsy for Noninvasive Early Lung Cancer Assessment

Wei, F., Strom, C. M., Cheng, J., Lin, C. C., Hsu, C. Y., Soo Hoo, G. W., Chia, D., Kim, Y., Li, F., Elashoff, D., Grognan, T., Tu, M., Liao, W., Xian, R., Grody, W. W., Su, W. C. & Wong, D. T. W., 2018 Nov, In : Journal of Molecular Diagnostics. 20, 6, p. 738-742 5 p.

Research output: Contribution to journalArticle

5 Citations (Scopus)
2019
Open Access

Tissue and plasma EGFR mutation analysis in the FLAURA trial: Osimertinib versus Comparator EGFR tyrosine kinase inhibitor as first-line treatment in patients with EGFR-mutated advanced non–small cell lung cancer

Gray, J. E., Okamoto, I., Sriuranpong, V., Vansteenkiste, J., Imamura, F., Lee, J. S., Pang, Y. K., Cobo, M., Kasahara, K., Cheng, Y., Nogami, N., Cho, E. K., Su, W. C., Zhang, G., Huang, X., Li-Sucholeiki, X., Lentrichia, B., Dearden, S., Jenkins, S., Saggese, M. & 2 others, Rukazenkov, Y. & Ramalingam, S. S., 2019 Nov 15, In : Clinical Cancer Research. 25, 22, p. 6644-6652 9 p.

Research output: Contribution to journalArticle

4 Citations (Scopus)
2020

Osimertinib plus savolitinib in patients with EGFR mutation-positive, MET-amplified, non-small-cell lung cancer after progression on EGFR tyrosine kinase inhibitors: interim results from a multicentre, open-label, phase 1b study

Sequist, L. V., Han, J. Y., Ahn, M. J., Cho, B. C., Yu, H., Kim, S. W., Yang, J. C. H., Lee, J. S., Su, W. C., Kowalski, D., Orlov, S., Cantarini, M., Verheijen, R. B., Mellemgaard, A., Ottesen, L., Frewer, P., Ou, X. & Oxnard, G., 2020 Mar, In : The Lancet Oncology. 21, 3, p. 373-386 14 p.

Research output: Contribution to journalArticle

5 Citations (Scopus)

Final Overall Survival and Other Efficacy and Safety Results From ASCEND-3: Phase II Study of Ceritinib in ALKi-Naive Patients With ALK-Rearranged NSCLC

Nishio, M., Felip, E., Orlov, S., Park, K., Yu, C. J., Tsai, C. M., Cobo, M., McKeage, M., Su, W. C., Mok, T., Scagliotti, G. V., Spigel, D. R., Viraswami-Appanna, K., Chen, Z., Passos, V. Q. & Shaw, A. T., 2020 Apr, In : Journal of Thoracic Oncology. 15, 4, p. 609-617 9 p.

Research output: Contribution to journalArticle

Open Access
1 Citation (Scopus)
2017

Association between GWAS-identified lung adenocarcinoma susceptibility loci and EGFR mutations in never-smoking Asian women, and comparison with findings from Western populations

Seow, W. J., Matsuo, K., Hsiung, C. A., Shiraishi, K., Song, M., NamKim, H., Wong, M. P., Hong, Y. C., Dean Hosgood, H., Wang, Z., Chang, I. S., Wang, J. C., Chatterjee, N., Tucker, M., Wei, H., Mitsudomi, T., Zheng, W., Kim, J. H., Zhou, B., Caporaso, N. E. & 166 others, Albanes, D., Shin, M. H., Chung, L. P., An, S. J., Wang, P., Zheng, H., Yatabe, Y., Zhang, X. C., Kim, Y. T., Shu, X. O., Kim, Y. C., Bassig, B. A., Chang, J., Man Ho, J. C., Ji, B. T., Kubo, M., Daigo, Y., Ito, H., Momozawa, Y., Ashikawa, K., Kamatani, Y., Honda, T., Sakamoto, H., Kunitoh, H., Tsuta, K., Watanabe, S. I., Nokihara, H., Miyagi, Y., Nakayama, H., Matsumoto, S., Tsuboi, M., Goto, K., Yin, Z., Shi, J., Takahashi, A., Goto, A., Minamiya, Y., Shimizu, K., Tanaka, K., Wu, T., Wei, F., Wong, J. Y. Y., Matsuda, F., Su, J., Kim, Y. H., Oh, I. J., Song, F., Lee, V. H. F., Su, W. C., Chen, Y. M., Chang, G. C., Chen, K. Y., Huang, M. S., Yang, P. C., Lin, H. C., Xiang, Y. B., Seow, A., Park, J. Y., Kweon, S. S., Chen, C. J., Li, H., Gao, Y. T., Wu, C., Qian, B., Lu, D., Liu, J., Jeon, H. S., Hsiao, C. F., Sung, J. S., Tsai, Y. H., Jung, Y. J., Guo, H., Hu, Z., Wang, W. C., Chung, C. C., Lawrence, C., Burdett, L., Yeager, M., Jacobs, K. B., Hutchinson, A., Berndt, S. I., He, X., Wu, W., Wang, J., Li, Y., Choi, J. E., Park, K. H., Sung, S. W., Liu, L., Kang, C. H., Hu, L., Chen, C. H., Yang, T. Y., Xu, J., Guan, P., Tan, W., Wang, C. L., Loon Sihoe, A. D., Chen, Y., Choi, Y. Y., Hung, J. Y., Kim, J. S., Yoon, H. I., Cai, Q., Lin, C. C., Park, I. K., Xu, P., Dong, J., Kim, C., He, Q., Perng, R. P., Chen, C. Y., Vermeulen, R., Wu, J., Lim, W. Y., Chen, K. C., Chan, J. K. C., Chu, M., Li, Y. J., Li, J., Chen, H., Yu, C. J., Jin, L., Lo, Y. L., Chen, Y. H., Fraumeni, J. F., Liu, J., Yamaji, T., Yang, Y., Hicks, B., Wyatt, K., Li, S. A., Dai, J., Ma, H., Jin, G., Song, B., Wang, Z., Cheng, S., Li, X., Ren, Y., Cui, P., Iwasaki, M., Shimazu, T., Tsugane, S., Zhu, J., Jiang, G., Fei, K., Wu, G., Chien, L. H., Chen, H. L., Su, Y. C., Tsai, F. Y., Chen, Y. S., Yu, J., Stevens, V. L., Laird-Offringa, I. A., Marconett, C. N., Lin, D., Chen, K., Wu, Y. L., Landi, M. T., Shen, H., Rothman, N., Kohno, T., Chanock, S. J. & Lan, Q., 2017 Jan 1, In : Human Molecular Genetics. 26, 2, p. 454-465 12 p.

Research output: Contribution to journalArticle

21 Citations (Scopus)

Cost-effectiveness of implementing computed tomography screening for lung cancer in Taiwan

Yang, S. C., Lai, W. W., Lin, C. C., Su, W. C., Ku, L. J., Hwang, J. S. & Wang, J. D., 2017 Jun 1, In : Lung Cancer. 108, p. 183-191 9 p.

Research output: Contribution to journalArticle

18 Citations (Scopus)

Chronic treatment with cisplatin induces chemoresistance through the TIP60-mediated Fanconi anemia and homologous recombination repair pathways

Su, W. P., Ho, Y. C., Wu, C. K., Hsu, S. H., Shiu, J. L., Huang, J. C., Chang, S. B., Chiu, W. T., Hung, J. J., Liu, T. L., Wu, W. S., Wu, P. Y., Su, W. C., Chang, J. Y. & Liaw, H., 2017 Dec 1, In : Scientific reports. 7, 1, 3879.

Research output: Contribution to journalArticle

3 Citations (Scopus)

Dysregulation of Rab37-mediated cross-talk between cancer cells and endothelial cells via thrombospondin-1 promotes tumor neovasculature and metastasis

Tzeng, H. T., Tsai, C. H., Yen, Y. T., Cheng, H. C., Chen, Y. C., Pu, S. W., Wang, Y. S., Shan, Y. S., Tseng, Y. L., Su, W. C., Lai, W. W., Wu, L. W. & Wang, Y. C., 2017 May 1, In : Clinical Cancer Research. 23, 9, p. 2335-2345 11 p.

Research output: Contribution to journalArticle

23 Citations (Scopus)
2016
7 Citations (Scopus)
2018
9 Citations (Scopus)

Osimertinib in untreated EGFR-Mutated advanced non-small-cell lung cancer

Soria, J. C., Ohe, Y., Vansteenkiste, J., Reungwetwattana, T., Chewaskulyong, B., Lee, K. H., Dechaphunkul, A., Imamura, F., Nogami, N., Kurata, T., Okamoto, I., Zhou, C., Cho, B. C., Cheng, Y., Cho, E. K., Voon, P. J., Planchard, D., Su, W. C., Gray, J. E., Lee, S. M. & 4 others, Hodge, R., Marotti, M., Rukazenkov, Y. & Ramalingam, S. S., 2018 Jan 11, In : New England Journal of Medicine. 378, 2, p. 113-125 13 p.

Research output: Contribution to journalArticle

866 Citations (Scopus)
2019

Psychometric evaluation of the WHOQOL-BREF, Taiwan version, across five kinds of Taiwanese cancer survivors: Rasch analysis and confirmatory factor analysis

Lin, C. Y., Hwang, J. S., Wang, W. C., Lai, W. W., Su, W. C., Wu, T. Y., Yao, G. & Wang, J. D., 2019 Jan, In : Journal of the Formosan Medical Association. 118, 1P2, p. 215-222 8 p.

Research output: Contribution to journalArticle

17 Citations (Scopus)
2017

Cabozantinib in hepatocellular carcinoma: Results of a phase 2 placebo-controlled randomized discontinuation study

Kelley, R. K., Verslype, C., Cohn, A. L., Yang, T. S., Su, W. C., Burris, H., Braiteh, F., Vogelzang, N., Spira, A., Foster, P., Lee, Y. & Van Cutsem, E., 2017 Jan 1, In : Annals of Oncology. 28, 3, p. 528-534 7 p.

Research output: Contribution to journalArticle

54 Citations (Scopus)
2019

A phase 1, open-label, dose-escalation trial of oral TSR-011 in patients with advanced solid tumours and lymphomas

Lin, C. C., Arkenau, H. T., Lu, S., Sachdev, J., de Castro Carpeño, J., Mita, M., Dziadziuszko, R., Su, W. C., Bobilev, D., Hughes, L., Chan, J., Zhang, Z. Y. & Weiss, G. J., 2019 Jul 16, In : British Journal of Cancer. 121, 2, p. 131-138 8 p.

Research output: Contribution to journalArticle

Open Access
2 Citations (Scopus)
2018

EGFR mutation analysis for prospective patient selection in AURA3 phase III trial of osimertinib versus platinum-pemetrexed in patients with EGFR T790M-positive advanced non-small-cell lung cancer

John, T., Akamatsu, H., Delmonte, A., Su, W. C., Lee, J. S., Chang, G. C., Huang, X., Jenkins, S. & Wu, Y. L., 2018 Dec, In : Lung Cancer. 126, p. 133-138 6 p.

Research output: Contribution to journalArticle

6 Citations (Scopus)

Randomized phase III study of docetaxel plus bavituximab in previously treated advanced non-squamous non-small-cell lung cancer

Gerber, D. E., Horn, L., Boyer, M., Sanborn, R., Natale, R., Palmero, R., Bidoli, P., Bondarenko, I., Germonpre, P., Ghizdavescu, D., Kotsakis, A., Lena, H., Losonczy, G., Park, K., Su, W. C., Tang, M., Lai, J., Kallinteris, N. L., Shan, J. S., Reck, M. & 1 others, Spigel, D. R., 2018 Jul 1, In : Annals of Oncology. 29, 7, p. 1548-1553 6 p.

Research output: Contribution to journalArticle

7 Citations (Scopus)
2020

Predicting lung cancer occurrence in never-smoking females in Asia: TNSF-SQ, a prediction model

Chien, L. H., Chen, C. H., Chen, T. Y., Chang, G. C., Tsai, Y. H., Hsiao, C. F., Chen, K. Y., Su, W. C., Wang, W. C., Huang, M. S., Chen, Y. M., Chen, C. Y., Liang, S. K., Chen, C. Y., Wang, C. L., Lee, M. H., Chung, R. H., Tsai, F. Y., Hu, J. W., Katki, H. A. & 8 others, Chatterjee, N., Chanock, S. J., Rothman, N., Lan, Q., Yang, P. C., Chen, C. J., Chang, I. S. & Hsiung, C. A., 2020 Feb 1, In : Cancer Epidemiology Biomarkers and Prevention. 29, 2, p. 452-459 8 p.

Research output: Contribution to journalArticle

Open Access